Evidence map›Paper›PMID 40379967›Full record

ArticleEuropean journal of human genetics : EJHG2026

Understanding speech and language in KIF1A-associated neurological disorder.

Lottie D Morison, Adam P Vogel, John Christodoulou, Wendy A Gold, Dylan Verden, Wendy K Chung, Ruth Braden, Joanna Bredebusch, Simranpreet Kaur, Ingrid E Scheffer and 1 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. New year, new insights in genomic medicine.European journal of human genetics : EJHG · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lottie D MorisonSpeech and Language Team, Murdoch Children's Research Institute, Parkville, VIC, Australia.ORCID 0000-0003-2822-6522
Adam P VogelDepartment of Audiology and Speech Pathology, The University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0002-3505-2631
John ChristodoulouBrain and Mitochondrial Group, Genomic Medicine, Murdoch Children's Research Institute, Parkville, VIC, Australia.ORCID 0000-0002-8431-0641
Wendy A GoldSchool of Medical Sciences, Faculty of Medicine Health, The University of Sydney, Sydney, NSW, Australia.
Dylan VerdenKIFA.org, San Francisco, CA, USA.
Wendy K ChungDepartment of Paediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3438-5685
Ruth BradenSpeech and Language Team, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Joanna BredebuschDepartment of Audiology and Speech Pathology, The University of Melbourne, Parkville, VIC, Australia.
Simranpreet Kaur *Brain and Mitochondrial Group, Genomic Medicine, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Ingrid E Scheffer *Department of Paediatrics, University of Melbourne, and Department of Neurology, Royal Children's Hospital, Parkville, VIC, Australia.
Angela T Morgan *Speech and Language Team, Murdoch Children's Research Institute, Parkville, VIC, Australia. angela.morgan@mcri.edu.au.ORCID 0000-0003-1147-7405

Funding

Role of the Kinesin KIF1A in Neurological DiseaseR01NS114636 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHUNG, WENDY K, GENNERICH, ARNE · 2020 to 2024
$3.2M
Department of Health | National Health and Medical Research Council (NHMRC) 1105008Department of Health | National Health and Medical Research Council (NHMRC) 1195955Department of Health | National Health and Medical Research Council (NHMRC) 2015727Department of Health | National Health and Medical Research Council (NHMRC) 2022156NINDS NIH HHS R01 NS114636U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 1R01NS114636
6 · The paper itself

Abstract

KIF1A-associated neurological disorder (KAND) is a genetic condition characterised by motor, cognitive and ophthalmologic features. The speech and language phenotype have not been systematically analysed. Here, we assess speech and language using observer- and clinician-reported outcomes, and performance outcome measures. 44 individuals (25 female) with KAND (median age 7 years, range 1-60 years) participated. Median age at diagnosis was 4 years (range 0.5-58 years). KIF1A variants were missense (41/44 individuals, 93%), intragenic deletion (2/44, 5%) and splice site (1/44, 2%). Age at first words was delayed (>12 months) in 38/44 (86%) individuals. At assessment, 28/44 (64%) combined words into sentences and all of the 20 individuals assessed had dysarthria. Apraxic speech features and phonological impairments occurred in children aged under 8 years. 36/37 (97%) participants had language impairment, with expressive language skills stronger than receptive (p = 0.02) and written (p = 0.03) language on the Vineland Adaptive Behaviour Scales. 7/32 (22%) caregivers reported speech and language regression. Mild to severe intellectual disability occurred in 31/33 (94%) individuals. 22/44 (50%) participants had used augmentative and alternative communication, such as key word sign or speech generating devices. Individuals had average social motivation skills in contrast to moderately impaired social cognition, communication and awareness on the Social Responsiveness Scale (p < 0.05). 16/44 (36%) had epilepsy and 40/44 (91%) had visual impairment, namely nystagmus (16/44, 36%), optic nerve atrophy and strabismus (both 12/44, 27%). Individuals with KAND frequently have speech and language disorders necessitating early and targeted speech and language interventions.

Indexed as

KinesinsNervous System DiseasesSpeechAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedPhenotypeYoung AdultKIF1A protein, humanKinesins

Identifiers

PMID40379967
PMCPMC12816008

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.